Heartbeam Stock Performance
| BEAT Stock | USD 1.77 0.04 2.21% |
Heartbeam holds a performance score of 6 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.66, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Heartbeam's returns are expected to increase less than the market. However, during the bear market, the loss of holding Heartbeam is expected to be smaller as well. Use Heartbeam coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to analyze future returns on Heartbeam.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Heartbeam are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Heartbeam unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Beyond Air Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update | 11/10/2025 |
2 | HeartBeam Poised in the Future of Cardiac Care With Breakthrough Technology | 11/20/2025 |
3 | HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application | 11/26/2025 |
4 | Unpacking Q3 Earnings Axon In The Context Of Other Aerospace and Defense Stocks | 12/01/2025 |
5 | A Look Back at Cybersecurity Stocks Q3 Earnings Zscaler Vs The Rest Of The Pack | 12/08/2025 |
6 | HeartBeam earns FDA clearance for first-ever cable-free 12-lead ECG for at-home arrhythmia assessment | 12/10/2025 |
7 | Oracle, Synopsys, Heartbeam, Planet Labs And Adobe Why These 5 Stocks Are On Investors Radars Today | 12/11/2025 |
8 | Disposition of 757 shares by Richard Brounstein of Heartbeam subject to Rule 16b-3 | 12/12/2025 |
9 | HeartBeam Stock Surges 388, With A 9-Day Winning Spree - Trefis | 12/16/2025 |
10 | HeartBeam Ranks Second Worldwide in 12-Lead ECG Innovation | 12/18/2025 |
11 | FDA Clearance for HeartBeam Highlighted in Medical Device Approvals Roundup | 01/09/2026 |
12 | HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer | 01/22/2026 |
| Begin Period Cash Flow | 16.2 M | |
| Total Cashflows From Investing Activities | -201 K |
Heartbeam | Build AI portfolio with Heartbeam Stock |
Heartbeam Relative Risk vs. Return Landscape
If you would invest 161.00 in Heartbeam on October 30, 2025 and sell it today you would earn a total of 16.00 from holding Heartbeam or generate 9.94% return on investment over 90 days. Heartbeam is currently generating 1.4052% in daily expected returns and assumes 16.817% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Heartbeam, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Heartbeam Target Price Odds to finish over Current Price
The tendency of Heartbeam Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.77 | 90 days | 1.77 | about 53.46 |
Based on a normal probability distribution, the odds of Heartbeam to move above the current price in 90 days from now is about 53.46 (This Heartbeam probability density function shows the probability of Heartbeam Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Heartbeam has a beta of 0.66 suggesting as returns on the market go up, Heartbeam average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Heartbeam will be expected to be much smaller as well. Moreover Heartbeam has an alpha of 1.1968, implying that it can generate a 1.2 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Heartbeam Price Density |
| Price |
Predictive Modules for Heartbeam
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Heartbeam. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Heartbeam Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Heartbeam is not an exception. The market had few large corrections towards the Heartbeam's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Heartbeam, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Heartbeam within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.20 | |
β | Beta against Dow Jones | 0.66 | |
σ | Overall volatility | 0.69 | |
Ir | Information ratio | 0.07 |
Heartbeam Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Heartbeam for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Heartbeam can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Heartbeam is way too risky over 90 days horizon | |
| Heartbeam may become a speculative penny stock | |
| Heartbeam appears to be risky and price may revert if volatility continues | |
| Heartbeam has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (19.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Heartbeam currently holds about 9.27 M in cash with (14.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.16. | |
| Roughly 24.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Resistance Check What is the long term forecast for Coeptis Therapeutics Holdings Inc Equity Warrant stock - 2025 Market Overview Safe Capital Preservation Plans - baoquankhu1.vn |
Heartbeam Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Heartbeam Stock often depends not only on the future outlook of the current and potential Heartbeam's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Heartbeam's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.6 M | |
| Cash And Short Term Investments | 2.4 M |
Heartbeam Fundamentals Growth
Heartbeam Stock prices reflect investors' perceptions of the future prospects and financial health of Heartbeam, and Heartbeam fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Heartbeam Stock performance.
| Return On Equity | -7.92 | ||||
| Return On Asset | -2.72 | ||||
| Current Valuation | 59.45 M | ||||
| Shares Outstanding | 34.44 M | ||||
| Price To Earning | 149.92 X | ||||
| Price To Book | 151.01 X | ||||
| EBITDA | (19.88 M) | ||||
| Net Income | (19.45 M) | ||||
| Cash And Equivalents | 9.27 M | ||||
| Cash Per Share | 1.16 X | ||||
| Total Debt | 1.62 M | ||||
| Debt To Equity | 0.52 % | ||||
| Current Ratio | 12.65 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (14.47 M) | ||||
| Earnings Per Share | (0.66) X | ||||
| Market Capitalization | 61.31 M | ||||
| Total Asset | 3.28 M | ||||
| Retained Earnings | (56.27 M) | ||||
| Working Capital | 1.15 M | ||||
| Current Asset | 47.05 M | ||||
| Current Liabilities | 23.89 M | ||||
About Heartbeam Performance
Assessing Heartbeam's fundamental ratios provides investors with valuable insights into Heartbeam's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Heartbeam is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 16.15 | 13.47 | |
| Return On Tangible Assets | (6.83) | (6.49) | |
| Return On Capital Employed | (13.83) | (13.14) | |
| Return On Assets | (6.83) | (7.17) | |
| Return On Equity | (13.52) | (12.85) |
Things to note about Heartbeam performance evaluation
Checking the ongoing alerts about Heartbeam for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Heartbeam help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Heartbeam is way too risky over 90 days horizon | |
| Heartbeam may become a speculative penny stock | |
| Heartbeam appears to be risky and price may revert if volatility continues | |
| Heartbeam has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (19.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Heartbeam currently holds about 9.27 M in cash with (14.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.16. | |
| Roughly 24.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Resistance Check What is the long term forecast for Coeptis Therapeutics Holdings Inc Equity Warrant stock - 2025 Market Overview Safe Capital Preservation Plans - baoquankhu1.vn |
- Analyzing Heartbeam's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Heartbeam's stock is overvalued or undervalued compared to its peers.
- Examining Heartbeam's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Heartbeam's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Heartbeam's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Heartbeam's stock. These opinions can provide insight into Heartbeam's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.